Chromium picolinate shows promise for teen skin condition linked to insulin resistance
NCT ID NCT07371169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether taking chromium picolinate daily for 24 weeks could reduce the severity of acanthosis nigricans (dark, thick skin patches) and improve insulin resistance in adolescents aged 12 to 18. Researchers compared the supplement to a placebo in 90 participants. The goal was to see if a simple supplement could help manage these conditions without major side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
chromium picolinate
What this could lead to
If it works, this could point toward a simple supplement to help manage skin changes and insulin resistance in teens.
What could go wrong
This is a small, completed trial with 90 participants, so results may not apply broadly. Chromium supplements can have side effects and may not be effective for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSULIN RESISTANCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baghdad Medical City / Children Welfare Teaching Hospital / Department of Endocrinology
Baghdad, Baghdad Governorate, 10045, Iraq